Biotechnology News and Research

RSS

Natural products to be developed as anti-cancer therapeutics

The licence grants Zentaris exclusive worldwide rights for the development, manufacture and marketing of disorazoles, a novel class of natural products with strong anti-cancer potential discovered by GBF researchers.

8 Jul 2004

Gum disease vaccination aim of world-first research

Vaccinating people against gum disease will be the aim of world-first Melbourne research that today receives a $21.2 million boost from the Federal Government.

2 Jul 2004

Omega-3's - fatty acids, can be produced in bioengineered plants

Long-chain omega-3 polyunsaturated fatty acids (n-3 LC-PUFAs) have benefits regarding cardiovascular and inflammatory function, certain types of cancer, and maternal and infant health, according to recent peer-reviewed studies.

2 Jul 2004

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

HIV is a moving target, unpredictably changing direction to elude anti-AIDS drugs, but researchers at Rutgers are clearly on the track of solutions to combat HIV drug resistance.

29 Jun 2004

Codex aims to keep up with gene technologies and potential health impact of genetically modified foods

The Codex Alimentarius Commission convened its 27th session today, one year ahead of schedule, amid calls for the Commission to implement recommendations made by Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) evaluation.

29 Jun 2004

UK launch of The Institute of Medical Law

The University of Birmingham is continuing to lead the way in international research into medical-legal issues such as MMR, euthanasia and drug regulation with the launch of The Institute of Medical Law.

29 Jun 2004

Exelixis files new drug application for a proprietary novel anticancer compound

Exelixis, Inc. has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) for XL999, a proprietary novel anticancer compound.

29 Jun 2004

Research for faster Polymerase Chain Reaction technology

Imagine being able to diagnose a viral strain at the site of an outbreak or identifying a deadly pathogen on the battlefield.

28 Jun 2004

Don't tell your Grandma! Brussel sprouts could help protect against cancer

“DNA damage is associated with cancer risk. Sources of DNA damage include diet-related carcinogens, and bodily processes like oxidative stress – and the raw sprouts protect against this kind of damage.

23 Jun 2004

New eye-tracking device

The newest research device at The William and Ida Friday Institute for Educational Innovation looks more like something out of a science fiction movie than a tool for discovering learning patterns.

21 Jun 2004

EU rules to govern tissue engineering

Tissue engineering - already used to build skin and bone - still holds enormous medical potential. The Commission plans to release a comprehensive package of EU rules to govern this promising field.

17 Jun 2004

£11.5m for new structural proteomics research

The Biotechnology and Biological Sciences Research Council (BBSRC) has announced that two new research projects will together receive nearly £11.5m under the Structural Proteomics of Rational Targets Initiative (SPORT).

17 Jun 2004

Biotech organization receives $1 million form Bill & Melinda Gates

The Biotechnology Industry Organization (BIO) today announced the launch of BIO Ventures for Global Health (BVGH), a new nonprofit organization that will work to enlist the biotechnology industry in the fight against neglected diseases. BVGH has received a $1 million start-up grant from the Bill & Melinda Gates Foundation.

17 Jun 2004

Real-Time Immuno-PCR has the ability to detect HIV infection earlier than all current methods

Researchers at the Institute of Human Virology have developed an ultra-sensitive testing technique that has shown the ability to detect HIV infection earlier than all current methods.

15 Jun 2004

University of Cambridge to generate antibodies

The University of Cambridge has announced a licensing agreement with Human-Human Hybridoma, Inc. (3H) to exploit a human myeloma cell line (Karpas-707H) that can be used in research and for the production of human monoclonal antibodies.

15 Jun 2004

New embryonic stem cells technology

An MIT team has developed new technology that could jump-start scientists' ability to create specific cell types from human embryonic stem cells, a feat with implications for developing replacement organs and a variety of other tissue engineering applications.

14 Jun 2004

John Kerry pushes for new cures and treatments for Alzheimer’s

Drawing on the inspiration of Nancy Reagan and millions of families who bravely comfort suffering loved ones, Democratic Presidential candidate John Kerry Saturday said we must lift the barriers that stand in the way of science to find new cures and treatments for Alzheimer’s and other diseases through stem cell research.

14 Jun 2004

Synthetic skin from human embryonic stem cells

A Massachusetts Institute of Technology team has developed new technology that could jump-start scientists' ability to create specific cell types from human embryonic stem cells, a feat with implications for developing replacement organs and a variety of other tissue engineering applications.

14 Jun 2004

Body fat not always bad

With the threat of an obesity crisis looming, a study led by UCL researchers reveals today that fat tissue isn’t always the enemy. Reporting in the journal Science they show that a molecular signalling pathway in fat tissue is an important mediator in extending lifespan.

11 Jun 2004

FDA approval for miniature robot for spinal procedures

A miniature robot for fail-proof spinal procedures has received FDA approval. Named SpineAssist, the robot is the brainchild of Technion-Israel Institute of Technology Mechanical Engineering Professor Moshe Shoham.

10 Jun 2004